In imatinib-resistant chronic-phase chronic myeloid leukemia (CML), upregulated GCA triggers TRAF6 ubiquitinase activity to induce K63-linked ULK1 ubiquitination and reduces K48-linked ubiquitination. The gene discussed is ULK1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.